Guidance Documents

Guidance Documents

Under 28 CFR 50.26, except where expressly authorized by law or as expressly incorporated into a contract, guidance documents issued by a Department component lack the force or effect of law and do not bind the public; noncompliance with voluntary standards will not, in itself, result in any enforcement action. In addition, 28 CFR 50.27 articulates processes and procedures for DOJ’s use of guidance documents, including the use of guidance documents in litigation.

Component Document Issued Posted ID Topic Overview
Drug Enforcement Administration (DEA) Not specified February 28, 2020 DOJ-1316651 General This informational pamphlet is aimed at health care professionals. It is a guide to show how they can recognize drug addiction with co-workers and/or a drug impaired co-workers. The information alerts the reader to certain signs, behaviors or symptoms that the drug impaired co-worker may exhibit. The material discusses things such as absenteeism, frequent disappearances, not meeting deadlines and work performances alternating between low and high periods of productivity. The material also identifies responsibilities and things that can be done to help the co-worker. The guide also provides signs that an individual maybe diverting controlled substances.
Drug Enforcement Administration (DEA) Not specified February 28, 2020 DOJ-1316656 Controlled Substance Prescriptions This information alerts the reader to certain signs, behaviors or symptoms that the drug impaired co-worker may exhibit. The material discusses things such as absenteeism, frequent disappearances, not meeting deadlines and work performances alternating between low and high periods of productivity. The material also gives the reader what are his/her responsibilities and things they can do to help to co-worker. The guide also provides signs that an individual maybe diverting controlled substances.
Drug Enforcement Administration (DEA) Not specified February 28, 2020 DOJ-1316661 General This pamphlet is directed to medical practitioners to assist them in recognizing a drug abuser, give them actions to take when confronted by a suspected drug abuser, and responsibilities regarding proper prescribing to prevent diversion. This includes common characteristics of the drug abuser and modus operandi often used by a drug-abusing patient.
Drug Enforcement Administration (DEA) Not specified February 28, 2020 DOJ-1316666 General Summary of the Combat Methamphetamine Epidemic Act of 2005 (CMEA). Preventing the Retail Diversion of Pseudoephedrine, including CMEA requirements, methamphetamine background information, and DEA’s goals in combating the methamphetamine epidemic.
Drug Enforcement Administration (DEA) Not specified February 28, 2020 DOJ-1316676 Controlled Substance Security This document identified a DEA regulation that may create unintended consequences for a formerly incarcerated individual that is attempting to successfully reenter society. Specifically, 21 CFR 1301.90 has been identified as such because this regulation sets forth specific questions in order for a non-practitioner to comprehensively screen employees. It also states DEA’s position on employee screening by non-practitioners in which “….obtaining information by non-practitioners is vital to fairly assess the likelihood of an employee committing a drug security breach. In this regard, it is believed that conviction of crimes and unauthorized use of controlled substances are activities that are properly subjects for injury.” Although 21 CFR 1301.90 has been identified, DEA would like to clarify that such regulation is only applicable to screening procedures for prospective employees at a non-practitioner DEA registered location where controlled substances are stored, distributed, manufactured, or otherwise handled and not applicable to prospective employees who will be employed at non-registered locations (ie corporate headquarters or sales offices).
Drug Enforcement Administration (DEA) Not specified February 28, 2020 DOJ-1316691 Controlled Substance Prescriptions

All records for prescribing of an FDA-approved narcotic for the treatment of opioid addiction need to be kept in accordance with 21 CFR 1304.03(c), 21 CFR 1304.21(b).

Drug Enforcement Administration (DEA) Not specified February 28, 2020 DOJ-1316711 General The document discusses ways for practitioners to be aware of signs that patients are trying to access drugs for diversion, such as giving vague symptoms, exaggerating pain, or avoiding tests and accessing medical history. The document also discusses ways for practitioners to avoid giving out prescriptions that could lead to diversion. Practitioners must assure they conduct medical examinations and tests while also looking out for signs of abuse when dealing with patients.
Office of Justice Programs (OJP) Not specified February 28, 2020 DOJ-1316776 Grants Guidance for states on the use and disposition requirements for VOI/TIS-funded facilities. 
Office of Justice Programs (OJP) Not specified February 28, 2020 DOJ-1316896 Grants Civil rights compliance information specific to State Administering Agencies for OJP awards during or prior to FY2016
Office of Justice Programs (OJP) Not specified February 28, 2020 DOJ-1316901 Grants Sample civil rights compliance checklist to assist state administering agencies in review of sub-recipients
Office of Justice Programs (OJP) Not specified February 28, 2020 DOJ-1316906 Grants Basic information on civil rights under the jursidiction of OCR and instructions on how to file a complaint with OCR.
U.S. Trustee Program Not specified February 28, 2020 UST-1317801 Credit Counseling & Debtor Education (Bankruptcy) Template letter explaining process and documentation for quality service review of approved credit counselors and debtor financial education providers.
U.S. Trustee Program Not specified February 28, 2020 UST-1317856 Bankruptcy Instructions for document production and participation in IDI for pro se debtors. USTP Region 1, Massachusetts.
U.S. Trustee Program Not specified February 28, 2020 UST-1317861 Business Reorganization (Bankruptcy) Instructions for document production and participation in Initial Debtor Interview for debtors. USTP Region 1, Massachusetts.
U.S. Trustee Program Not specified February 28, 2020 UST-1317921 Bankruptcy Instructions as to how to implement LAP program. USTP Region 2.
U.S. Trustee Program Not specified February 28, 2020 UST-1317926 Bankruptcy Instructions for document production and participation in IDI for pro se corporate debtors. USTP Region 2, Brooklyn.
U.S. Trustee Program Not specified February 28, 2020 UST-1317931 Bankruptcy Instructions for document production and participation in IDI for pro se single asset real estate debtors. USTP Region 2, Brooklyn.
U.S. Trustee Program Not specified February 28, 2020 UST-1317936 Business Reorganization (Bankruptcy) Instructions provided to debtors following IDI requesting additional information and confirming information explained in IDI. USTP Region 2.
U.S. Trustee Program Not specified February 28, 2020 UST-1317941 Business Reorganization (Bankruptcy) Instructions for Chapter 11 Trustees to explain obligations and duties to appointed trustees. USTP Region 2.
U.S. Trustee Program Not specified February 28, 2020 UST-1317946 Business Reorganization (Bankruptcy) Instructions for completing post confirmation reports. USTP Region 2.
U.S. Trustee Program Not specified February 28, 2020 UST-1317951 Bankruptcy Trustee elections questionnaire for creditors with instructions. USTP Region 2.
U.S. Trustee Program Not specified February 28, 2020 UST-1317956 Bankruptcy Instructions to debtor regarding compliance with obligation to comply with obligation to obtain credit counseling. USTP Region 2.
U.S. Trustee Program Not specified February 28, 2020 UST-1317961 Bankruptcy Instructions to debtor regarding obligation to file pay advices. USTP Region 2.
U.S. Trustee Program Not specified February 28, 2020 UST-1317966 Business Reorganization (Bankruptcy) Instructions to debtor regarding obligation to notify UST of expiring insurance. USTP Region 2.
U.S. Trustee Program Not specified February 28, 2020 UST-1317971 Bankruptcy Inquiry and Instructions to debtors following conversion from chapter 13 to chapter 7. USTP Region 2.

Pages

Was this page helpful?

Was this page helpful?
Yes No